Banner Publications MH200828 N141

Publications

Results found: 7858

Showing results: 101 - 150

Cancer discovery

IL-2 targeted to CD8+ T cells promotes robust effector T cell responses and potent antitumor immunity.

02-04-2024
Cancer discovery

CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool.

02-04-2024
JAMA

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

02-04-2024
PLoS neglected tropical diseases

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.

01-04-2024
The Lancet regional health. Europe

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.

01-04-2024
Cancer gene therapy

Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.

01-04-2024
Cellular & molecular immunology

CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.

01-04-2024
JAMA network open

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

01-04-2024
Life science alliance

Variety in the USP deubiquitinase catalytic mechanism.

01-04-2024
Annals of oncology : official journal of the European Society for Medical Oncology

Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.

01-04-2024
Molecular pharmaceutics

Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.

01-04-2024
Clinical cancer research : an official journal of the American Association for Cancer Research

Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer.

01-04-2024
European journal of cancer (Oxford, England : 1990)

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

01-04-2024
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Redispensing of expensive oral anticancer medicines: A practical application.

01-04-2024
Nature

Publisher Correction: Decoding chromatin states by proteomic profiling of nucleosome readers.

01-04-2024
Protein science : a publication of the Protein Society

Conserved proline residues prevent dimerization and aggregation in the β-lactamase BlaC.

01-04-2024
Breast (Edinburgh, Scotland)

Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now.

01-04-2024
Journal of biomedical optics

Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy.

01-04-2024
Magnetic resonance imaging

On retrospective k-space subsampling schemes for deep MRI reconstruction.

01-04-2024
Pharmaceutical research

Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.

01-04-2024
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society

Dynamic recurrent inference machines for accelerated MRI-guided radiotherapy of the liver.

01-04-2024
Journal of cancer survivorship : research and practice

Correction to: Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

01-04-2024
Cancer chemotherapy and pharmacology

Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.

01-04-2024
Journal of cancer survivorship : research and practice

Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints.

01-04-2024
FEBS letters

EU-LIFE charter of independent life science research institutes.

01-04-2024
Clinical genitourinary cancer

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

01-04-2024
Toxicology and applied pharmacology

The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib.

01-04-2024
European journal of radiology

Artificial intelligence and explanation: How, why, and when to explain black boxes.

01-04-2024
ESMO open

Elements of successful patient involvement in clinical cancer trials: a review of the literature.

01-04-2024
Physics and imaging in radiation oncology

A deep learning based dynamic arc radiotherapy photon dose engine trained on Monte Carlo dose distributions.

01-04-2024
The Lancet. Oncology

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.

01-04-2024
Dysphagia

Dysphagia After Total Laryngectomy: An Exploratory Study and Clinical Phase II Rehabilitation Trial with the Novel Swallowing Exercise Aid (SEA 2.0).

01-04-2024
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment.

29-03-2024
Cell

Generating and using real-world data: A worthwhile uphill battle.

28-03-2024
Communications biology

GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation.

28-03-2024
Cell

Embracing cancer complexity: Hallmarks of systemic disease.

28-03-2024
Cancer discovery

Paradoxical activation of oncogenic signaling as a cancer treatment strategy.

27-03-2024
Journal for immunotherapy of cancer

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

26-03-2024
Health and quality of life outcomes

Acceptability and usefulness of the EORTC 'Write In three Symptoms/Problems' (WISP): a brief open-ended instrument for symptom assessment in cancer patients.

26-03-2024
Cancer journal (Sudbury, Mass.)

Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma.

25-03-2024
British journal of cancer

Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma.

22-03-2024
Nature communications

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

22-03-2024
Molecular cell

Transcription factor exchange enables prolonged transcriptional bursts.

21-03-2024
Nature communications

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.

21-03-2024
Molecular cell

Visualization of translation reorganization upon persistent ribosome collision stress in mammalian cells.

21-03-2024
Cell reports. Medicine

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse.

19-03-2024
Annals of oncology : official journal of the European Society for Medical Oncology

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.

13-03-2024
European radiology

Artificial intelligence-assisted double reading of chest radiographs to detect clinically relevant missed findings: a two-centre evaluation.

11-03-2024
Cancer cell

Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer.

11-03-2024
Cancer chemotherapy and pharmacology

Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment.

08-03-2024

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.